Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This pharmaceutical grade peptide demonstrates superior efficacy in glucose control and weight management compared to similar compounds.
Our high purity Tirzepatide (99.9%) is supplied as white powder in sterile vials, available in multiple concentrations for research applications. The compound features a unique molecular structure with PEG modification that enhances water solubility and biological activity.
Clinical studies indicate significant weight loss potential, with trial participants showing 15-20.9% reduction in body weight over 72 weeks depending on dosage. Tirzepatide has received FDA Fast Track designation for obesity-related research applications.
For researchers looking to buy tirzepatide online, we offer flexible packaging options including custom vial quantities and labeling. Our production facility maintains strict quality control standards for all peptide products.
As a dual agonist, Tirzepatide combines the effects of two metabolic regulators in a single molecule, representing an innovative approach to diabetes and weight management research. The compound mimics natural GIP action while providing enhanced GLP-1 receptor activity.
Storage recommendations: Maintain in cool, dry conditions protected from light. Avoid repeated freeze-thaw cycles and prolonged solution storage for optimal stability.
